Colgate-Palmolive (CL) Stock Price, News & Analysis

Company Overview

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Key Stats

• Today's Range: $91.46 to $93.15
• 50-Day Range: $90.21 to $101.59
• 52-Week Range: $76.96 to $109.30
• Volume: 9.77 million shs
• Average Volume: 4.42 million shs
• Market Capitalization: $75.19 billion
• P/E Ratio: 26.37
• Dividend Yield: 2.17%
• Price Target: $105.11
• Consensus Rating: Moderate Buy

Colgate-Palmolive Stock Analysis - MarketRank™

Colgate-Palmolive scored higher than 98% of companies evaluated by MarketBeat, and ranked 3rd out of 146 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Colgate-Palmolive has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 12 buy ratings, 9 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Colgate-Palmolive has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.80%

Earnings Growth

Earnings for Colgate-Palmolive are expected to grow by 7.80% in the coming year, from $3.59 to $3.87 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Colgate-Palmolive is 26.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.76.

Price to Earnings Ratio vs. Sector

The P/E ratio of Colgate-Palmolive is 26.37, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 21.97.

Price to Earnings Growth Ratio

Colgate-Palmolive has a PEG Ratio of 3.31. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Colgate-Palmolive has a P/B Ratio of 79.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.09% of the float of Colgate-Palmolive has been sold short.

Short Interest Ratio / Days to Cover

Colgate-Palmolive has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Colgate-Palmolive has recently decreased by 20.45%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Colgate-Palmolive pays a meaningful dividend of 2.15%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Colgate-Palmolive has been increasing its dividend for 62 years.

Dividend Coverage

The dividend payout ratio of Colgate-Palmolive is 57.31%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Colgate-Palmolive will have a dividend payout ratio of 51.68% next year. This indicates that Colgate-Palmolive will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 2.9 / 5
• Environmental Score: -2.16

Percentage of Shares Shorted

1.09% of the float of Colgate-Palmolive has been sold short.

Short Interest Ratio / Days to Cover

Colgate-Palmolive has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Colgate-Palmolive has recently decreased by 20.45%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.88

News Sentiment

Colgate-Palmolive has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Colgate-Palmolive this week, compared to 14 articles on an average week.

Search Interest

Only 11 people have searched for CL on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.

MarketBeat Follows

Only 6 people have added Colgate-Palmolive to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Colgate-Palmolive insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,273,535.00 in company stock.

Percentage Held by Insiders

Only 0.34% of the stock of Colgate-Palmolive is held by insiders.

Percentage Held by Institutions

80.41% of the stock of Colgate-Palmolive is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CL Stock Analysis - Frequently Asked Questions

How have CL shares performed this year?

Colgate-Palmolive's stock was trading at $79.71 on January 1st, 2024. Since then, CL stock has increased by 15.5% and is now trading at $92.03.
View the best growth stocks for 2024 here.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) released its quarterly earnings data on Friday, October, 27th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.06. The firm's revenue for the quarter was up 10.3% on a year-over-year basis.
Read the conference call transcript.

Does Colgate-Palmolive have any subsidiaries?

The following companies are subsidiaries of Colgate-Palmolive: Hello Products, EltaMD, PCA SKIN, Laser Brand Toothpaste, Sanex, Tom's of Maine, GABA International, and more.

Who are Colgate-Palmolive's major shareholders?

Top institutional investors of Colgate-Palmolive include State Street Corp (5.93%), Geode Capital Management LLC (2.47%), Wellington Management Group LLP (1.86%) and Massachusetts Financial Services Co. MA (1.17%). Insiders that own company stock include Noel R Wallace, Jennifer Daniels, Philip G Shotts, Stanley J Sutula III, Lorrie M Norrington, John P Bilbrey, C Martin Harris, Sally Massey, Prabha Parameswaran, Stephen I Sadove, Martina Hundmejean, Gregory Malcolm, Panagiotis Tsourapas, John W Kooyman, John T Cahill and Patricia Verduin.
View institutional ownership trends.

How do I buy shares of Colgate-Palmolive?

Shares of CL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Colgate-Palmolive investors own include Chevron (CVX), Bristol-Myers Squibb (BMY), Comcast (CMCSA), Exxon Mobil (XOM), Walmart (WMT), Johnson & Johnson (JNJ) and Charles Schwab (SCHW).

Company Calendar

• Last Earnings: 10/27/2023
• Ex-Dividend for 11/15 Dividend: 10/18/2024
• Dividend Payable: 11/15/2024
• Today: 12/23/2024
• Fiscal Year End: 12/31/2024
• Ex-Dividend for 2/14 Dividend: 1/21/2025
• Dividend Payable: 2/14/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Toilet preparations
• Sub-Industry: Household Products
• Current Symbol: NYSE:CL
• CUSIP: 19416210
• CIK: 21665
• Web: www.colgatepalmolive.com
• Phone: (212) 310-2000
• Fax: 212-310-3284
• Employees: 34,000
• Year Founded: 1806

Price Target and Rating

• Average Stock Price Target: $105.11
• High Stock Price Target: $122.00
• Low Stock Price Target: $91.00
• Potential Upside/Downside: +14.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 22 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.49
• Trailing P/E Ratio: 26.37
• Forward P/E Ratio: 25.64
• P/E Growth: 3.31
• Net Income: $2.30 billion
• Net Margins: 14.27%
• Pretax Margin: 19.65%
• Return on Equity: 405.81%
• Return on Assets: 17.72%

Debt

• Debt-to-Equity Ratio: 9.46
• Current Ratio: 1.04
• Quick Ratio: 0.68

Sales & Book Value

• Annual Sales: $20.11 billion
• Price / Sales: 3.74
• Cash Flow: $3.91 per share
• Price / Cash Flow: 23.51
• Book Value: $1.16 per share
• Price / Book: 79.34

Miscellaneous

• Outstanding Shares: 817,011,000
• Free Float: 814,233,000
• Market Cap: $75.19 billion
• Optionable: Optionable
• Beta: 0.43